Propiedad y actividad de insiders de Maravai LifeSciences Holdings, Inc. (MRVI): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $6.84 |
| Capitalización | $1.9B |
| Bolsa | NASDAQ |
| País | US |
Operaciones Recientes de Insiders
| Fecha | Insider | Tipo | Acciones | Valor |
|---|---|---|---|---|
| 2026-09-08 | Brust Bernd | F-InKind | 29,250 | $214K |
| 2026-08-31 | Asarpota Rajesh | F-InKind | 5,465 | $42K |
| 2026-08-10 | Brust Bernd | F-InKind | 29,250 | $182K |
| 2026-07-30 | Asarpota Rajesh | F-InKind | 5,465 | $36K |
| 2026-07-08 | Brust Bernd | F-InKind | 29,250 | $173K |
| 2026-06-30 | Asarpota Rajesh | F-InKind | 65,584 | $419K |
| 2026-06-08 | Brust Bernd | F-InKind | 351,001 | $1.8M |
| 2026-06-09 | ORESHACK KURT | S-Sale | 25,000 | $126K |
| 2026-06-10 | ORESHACK KURT | S-Sale | 25,000 | $127K |
| 2026-06-09 | LUCIER GREGORY T | G-Gift | 46,293 |
Balance (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $21.9M | $24.7M | $236.2M | $551.3M | $632.1M | $575.0M | $322.4M | $216.9M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $16.0M | $18.0M | $51.0M | $117.5M | $146.8M | $55.7M | $38.5M | $25.5M |
| Inventario | $14.3M | $14.2M | $33.3M | $51.6M | $43.2M | $51.4M | $50.1M | $40.5M |
| Activos Corrientes | $53.8M | $60.6M | $331.6M | $740.0M | $847.9M | $699.9M | $429.1M | $296.3M |
| Inmovilizado Material | $42.6M | $94.3M | $101.3M | $95.4M | $116.6M | $222.6M | $217.0M | $1.2M |
| Fondo de Comercio | $224.3M | $224.3M | $224.3M | $152.8M | $283.7M | $326.0M | $159.9M | $129.4M |
| Activos Intangibles | $218.1M | $197.9M | $177.7M | $117.6M | $216.7M | $221.0M | $195.0M | $151.5M |
| Activos Totales | $539.7M | $577.8M | $1.27B | $1.92B | $2.28B | $1.49B | $1.01B | $770.6M |
| Cuentas por Pagar | $3.6M | $7.5M | $3.0M | $8.2M | $6.0M | $10.7M | $12.0M | 0 |
| Deuda a Corto | $2.5M | $2.5M | $6.0M | $6.0M | $5.4M | $5.4M | $5.4M | $5.4M |
| Pasivos Corrientes | $35.9M | $29.6M | $130.8M | $93.8M | $110.1M | $87.5M | $57.0M | $44.9M |
| Deuda a Largo | $335.6M | $334.8M | $528.6M | $524.6M | $522.0M | $518.7M | $290.5M | $30.1M |
| Pasivos Totales | $391.7M | $433.2M | $1.12B | $1.37B | $1.38B | $697.6M | $431.0M | $397.9M |
| Reservas | -$38.2M | -$42.4M | $854000 | $184.6M | $404.8M | $285.7M | $140.9M | $10.1M |
| Patrimonio Neto | $144.4M | $141.4M | $88.5M | $315.5M | $545.2M | $416.8M | $325.3M | $212.4M |
| Deuda Total | $339.9M | $390.2M | $590.8M | $575.2M | $585.3M | $611.0M | $376.7M | $35.6M |
| Deuda Neta | $318.0M | $365.5M | $354.6M | $23.9M | -$46.9M | $36.0M | $54.3M | -$181.3M |
| Capital Circulante | $17.9M | $31.0M | $200.8M | $646.3M | $737.8M | $612.4M | $372.2M | $251.3M |
Salud financiera
| Deuda / Patrimonio | 0.86 |
| Ratio corriente | 4.05 |
| Piotroski F-Score | 2 |
| Altman Z-Score | 1.98 |
Rentabilidad
| Rentabilidad sobre capital | -61.58% |
| Rentabilidad sobre capital invertido | -0.91% |
| Rentabilidad sobre activos | -16.97% |
| Margen bruto | 34.61% |
| Margen operativo | 46.02% |
| Margen neto | -37.07% |
Empresas relacionadas: BCAX · DNA · IOVA · KURA · LENZ · PRME · REPL
Explorar sector: Healthcare · Biotechnology
Más secciones de MRVI: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones